NCT05023434: A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must have a clinical indication for an awake craniotomy

Comments are closed.

Up ↑